Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet. 2018

Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, Japan.

During middle age, women are less susceptible to nonalcoholic steatohepatitis (NASH) than men. Thus, we investigated the underlying molecular mechanisms behind these sexual differences using an established rat model of NASH. Mature female and male stroke-prone spontaneously hypertensive 5/Dmcr rats were fed control or high-fat-cholesterol (HFC) diets for 2, 8, and 14 weeks. Although HFC-induced hepatic fibrosis was markedly less severe in females than in males, only minor gender differences were observed in expression levels of cytochrome P450 enzymes (CYP)7A1, CYP8B1 CYP27A1, and CYP7B1, and multidrug resistance-associated protein 3, and bile salt export pump, which are involved in fibrosis-related bile acid (BA) kinetics. However, the BA detoxification-related enzymes UDP-glucuronosyltransferase (UGT) and sulfotransferase (SULT) 2A1, and the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR), were strongly suppressed in HFC-fed males, and were only slightly changed in HFC-diet fed females. Expression levels of the farnesoid X receptor and its small heterodimer partner were similarly regulated in a gender-dependent fashion following HFC feeding. Hence, the pronounced female resistance to HFC-induced liver damage likely reflects sustained expression of the nuclear receptors CAR and PXR and the BA detoxification enzymes UGT and SULT.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011987 Receptors, Steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. Corticosteroid Receptors,Receptors, Corticosteroid,Steroid Receptors,Corticosteroid Receptor,Receptors, Steroids,Steroid Receptor,Receptor, Corticosteroid,Receptor, Steroid,Steroids Receptors
D002791 Cholesterol, Dietary Cholesterol present in food, especially in animal products. Dietary Cholesterol
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005260 Female Females
D000077297 Pregnane X Receptor Steroid receptor that binds and is activated by variety of endogenous compounds and XENOBIOTICS. It binds the response element in promoters of genes that encode CYTOCHROME P450 3A4 and ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 proteins, and also activates the transcription of multiple genes involved in the metabolism and secretion of potentially harmful xenobiotics, drugs, and endogenous compounds. It is activated by the antibiotic RIFAMPICIN and various plant metabolites, such as hyperforin, guggulipid, colupulone, and ISOFLAVONES. NR1I2,Nuclear Receptor Subfamily 1, Group I, Member 2,SXR Receptor,Steroid X Receptor,Steroid and Xenobiotic Receptor
D000090702 Constitutive Androstane Receptor A member of the nuclear receptor superfamily (subfamily 1, group I, member 3 [NR1i3]) involved, along with PREGNANE X RECEPTOR, in regulation of cellular responses to the exogenous and endogenous chemicals such as detoxification of XENOBIOTICS. CAR Nuclear Receptor,CAR Orphan Nuclear Receptor,Constitutive Active Receptor,Constitutive Androstane Receptor beta,Active Receptor, Constitutive,Androstane Receptor, Constitutive,Nuclear Receptor, CAR,Receptor, CAR Nuclear,Receptor, Constitutive Active

Related Publications

Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
August 2023, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
May 2018, Journal of atherosclerosis and thrombosis,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
May 2012, Environmental health and preventive medicine,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
November 2012, Environmental health and preventive medicine,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
October 1976, Atherosclerosis,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
January 1986, Hepatology (Baltimore, Md.),
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
August 2022, International journal of molecular sciences,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
January 2009, Advances in experimental medicine and biology,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
March 2022, International journal of molecular sciences,
Husna Yetti, and Hisao Naito, and Yuan Yuan, and Xiaofang Jia, and Yumi Hayashi, and Hazuki Tamada, and Kazuya Kitamori, and Katsumi Ikeda, and Yukio Yamori, and Tamie Nakajima
February 1994, The Journal of nutrition,
Copied contents to your clipboard!